These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37033235)

  • 41. Inflammatory status, body composition and ethnic differences in bone mineral density: The Southall and Brent Revisited Study.
    Durdin R; Parsons C; Dennison EM; Williams S; Tillin T; Chaturvedi N; Cooper C; Harvey NC; Ward KA
    Bone; 2022 Feb; 155():116286. PubMed ID: 34890861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer.
    Love RR; Young GS; Laudico AV; Van Dinh N; Uy GB; Quang le H; De La Peña AS; Dofitas RB; Bisquera OC; Siguan SS; Salvador JD; Mirasol-Lumague MR; Navarro NS; Linh ND; Jarjoura D
    Cancer; 2013 Nov; 119(21):3746-52. PubMed ID: 23963821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density.
    Napoli N; Villareal DT; Mumm S; Halstead L; Sheikh S; Cagaanan M; Rini GB; Armamento-Villareal R
    J Bone Miner Res; 2005 Feb; 20(2):232-9. PubMed ID: 15647817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone mineral content and areal density, but not bone area, predict an incident fracture risk: a comparative study in a UK prospective cohort.
    Curtis EM; Harvey NC; D'Angelo S; Cooper CS; Ward KA; Taylor P; Pearson G; Cooper C
    Arch Osteoporos; 2016 Dec; 11(1):39. PubMed ID: 27915448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective estrogen receptor modulator lasofoxifene suppresses spondyloarthritis manifestation and affects characteristics of gut microbiota in zymosan-induced SKG mice.
    Jeong H; Kim IY; Bae EK; Jeon CH; Ahn KS; Cha HS
    Sci Rep; 2021 Jun; 11(1):11923. PubMed ID: 34099783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of estradiol on bone mineral density is modulated by the specific estrogen receptor-alpha cofactor retinoblastoma-interacting zinc finger protein-1 insertion/deletion polymorphism.
    Grundberg E; Akesson K; Kindmark A; Gerdhem P; Holmberg A; Mellström D; Ljunggren O; Orwoll E; Mallmin H; Ohlsson C; Brändström H
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2300-6. PubMed ID: 17356055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
    Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
    Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
    Massai R; Mäkäräinen L; Kuukankorpi A; Klipping C; Duijkers I; Dieben T
    Hum Reprod; 2005 Oct; 20(10):2764-8. PubMed ID: 15980008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The oxidative metabolism of estradiol conditions postmenopausal bone density and bone loss.
    Leelawattana R; Ziambaras K; Roodman-Weiss J; Lyss C; Wagner D; Klug T; Armamento-Villareal R; Civitelli R
    J Bone Miner Res; 2000 Dec; 15(12):2513-20. PubMed ID: 11127217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement.
    Popat VB; Calis KA; Kalantaridou SN; Vanderhoof VH; Koziol D; Troendle JF; Reynolds JC; Nelson LM
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3418-26. PubMed ID: 24905063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postmenopausal bone mineral density: relationship to calcium intake, calcium absorption, residual estrogen, body composition, and physical activity.
    Hoover PA; Webber CE; Beaumont LF; Blake JM
    Can J Physiol Pharmacol; 1996 Aug; 74(8):911-7. PubMed ID: 8960380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
    Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
    Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The comparative effect of ovarian hormone administration on bone mineral status in oophorectomized rats.
    Barbagallo M; Carbognani A; Palummeri E; Chiavarini M; Pedrazzoni M; Bracchi PG; Passeri M
    Bone; 1989; 10(2):113-6. PubMed ID: 2765309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Body composition and reproductive function exert unique influences on indices of bone health in exercising women.
    Mallinson RJ; Williams NI; Hill BR; De Souza MJ
    Bone; 2013 Sep; 56(1):91-100. PubMed ID: 23702387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship of homocysteine levels with lumbar spine and femur neck BMD in postmenopausal women.
    Bahtiri E; Islami H; Rexhepi S; Qorraj-Bytyqi H; Thaçi K; Thaçi S; Karakulak C; Hoxha R
    Acta Reumatol Port; 2015; 40(4):355-62. PubMed ID: 26922199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Association of Gut Microbiota With Osteoporosis Is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort.
    Ling CW; Miao Z; Xiao ML; Zhou H; Jiang Z; Fu Y; Xiong F; Zuo LS; Liu YP; Wu YY; Jing LP; Dong HL; Chen GD; Ding D; Wang C; Zeng FF; Zhu HL; He Y; Zheng JS; Chen YM
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3852-e3864. PubMed ID: 34214160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
    van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
    JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss.
    Vilarrasa N; Gómez JM; Elio I; Gómez-Vaquero C; Masdevall C; Pujol J; Virgili N; Burgos R; Sánchez-Santos R; de Gordejuela AG; Soler J
    Obes Surg; 2009 Jul; 19(7):860-6. PubMed ID: 19412643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
    Dolan SE; Kanter JR; Grinspoon S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2938-45. PubMed ID: 16735489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FSH Level and Changes in Bone Mass and Body Composition in Older Women and Men.
    Wu KC; Ewing SK; Li X; Sigurðsson S; Guðnason V; Kado DM; Hue TF; Woods GN; Veldhuis-Vlug AG; Vittinghoff E; Zaidi M; Rosen CJ; Lang T; Kim TY; Schwartz AV; Schafer AL
    J Clin Endocrinol Metab; 2021 Sep; 106(10):2876-2889. PubMed ID: 34212197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.